Tom Allen serves as Executive at Syneos Health, Inc., where they oversee executive responsibilities. Since joining the company, Tom Allen has executed 9 insider transactions totaling $1.6B, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 7, 2021 involved selling 6,033,668 shares valued at $489.9M.
Tom Allen currently holds 273,821 shares of Syneos Health, Inc. (SYNH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tom Allen has been a net seller of SYNH stock. They have purchased $0 and sold $1.6B worth of shares.
Tom Allen's most recent insider trade was on Jun 7, 2021, when they sold 6,033,668 shares at $81.20 per share.
Get notified when new Form 4 filings are submitted
| $81.20 |
| Discretionary |
| May 14, 2021 | SYNH | $36.4M | Sale | 448,942 | $81.04 | Discretionary |
| May 6, 2021 | SYNH | $17.6M | Sale | 216,666 | $81.04 | Discretionary |
| May 6, 2021 | SYNH | $307.3M | Sale | 3,791,652 | $81.04 | Discretionary |
| Mar 3, 2021 | SYNH | $321.3M | Sale | 4,331,222 | $74.18 | Discretionary |
| Mar 3, 2021 | SYNH | $23.9M | Sale | 322,824 | $74.18 | Discretionary |
| Dec 3, 2020 | SYNH | $197.8M | Sale | 3,228,241 | $61.28 | Discretionary |
| Sep 17, 2020 | SYNH | $223.2M | Sale | 3,766,281 | $59.26 | Discretionary |